mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |